Corrigendum to "Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments": [Annals of Oncology 34 (2023) 543-552]
Ann Oncol. 2024 Aug 12:S0923-7534(23)00796-2.
doi: 10.1016/j.annonc.2023.07.010.
Online ahead of print.
1 Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
2 Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
3 Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; The Institute of Cancer Research, London, UK.
4 Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
5 Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
6 Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain.
7 Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
8 Medical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
9 Medical Oncology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: meelez@vhio.net.